Brief: HLB Life Science lowers conversion price of 4th series convertible bonds to 5,860 won/share
Feb 7 (Reuters) - HLB Life Science Co Ltd 067630.KQ :
* Says it lowered conversion price of 4th series
unregistered and unsecured private convertible bonds to 5,860
won/share from 6,056 won/share, effective Feb. 4
Source text in Korean: https://goo.gl/H57K5O
Further company coverage: 067630.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on HLB Life Science
See all newsBrief: Hlb Life Science To Divest 36 Billion Won Worth Of Shares In Affiliate Hlb Cell
Moody's announces completion of a periodic review of ratings of EnergySolutions, LLC
Moody's affirms EnergySolutions' ratings with senior secured and CFR at B3; outlook to stable
Moody's announces completion of a periodic review of ratings of EnergySolutions, LLC
Moody's downgrades EnergySolutions' CFR to B3; outlook is negative